Vischer advised the co-lead and other new investors in Aktiia’s oversubscribed USD 42m Series-B funding-round. Pursuant to the transaction, the blood pressure intelligence platform reached a total funding of USD 100m to date. The
Tags :Vischer
Vischer advised the Matignon Group on its acquisition of 100% of the shares of Meon Clinic and Meon Center, based in Lucerne and Meggen. The company Headquartered in Paris, aesthetic medicine and surgery specialist Matignon Group
Vischer advised MCH Group and Bits & Pretzels in joining forces under the joint venture health.tech events and creating health.tech global summit, an international conference for digital innovations in healthcare. The context Rooted
Walder Wyss and Vischer are amongst the firms involved in Granite Bio’s Series A and Series B financing round. In particular Vischer advised Forbion and Sanofi Ventures on all legal issues related to their
Vischer advised Atanis Biotech, a Swiss biotechnology company, to successful completion of an oversubscribed financing round. The financing round The proceeds from this operation will fund the European and North-American marketing campaigns for Atanis’s “
As of January 2025, Anela Lucic (pictured) has been promoted to partner at Vischer, a firm she has been part of since 2014. The profile Anela Lucic’s area of practice includes advising and representing national and
Advestra advised Liberta Partner, a Munich-based multi-family office, on its acquisition of a majority stake in Avenir Group, a human resource management company headquartered in Switzerland, advised by Vischer. Furthermore, Baker McKenzie advised Migros Bank
Vischer advised Ikerian, a healthcare software platform company, on its first round of USD 8m Series B financing to advance its AI platform. The Series B financing round is led by strategic investor Sanoptis led
Vischer has acted as legal advisor to MegaCAD GmbH in its acquisition of Bausoft Informatik AG, a leading Swiss software company specialising in CAD solutions for the building engineering sector. Since its founding in 1994, Bausoft
Vischer acted as Swiss counsel to the founders of Santis Pharma on its partnership with Abenex, in collaboration with lead counsel Archer Avocats. Accompanied by its new partner, Santis Pharma aims at accelerating its expansion
